SCHEDULE 13G/A: RTW Investments and Dr. Roderick Wong Disclose 5.5% Stake in Immatics N.V.
Beneficial Ownership Report (Schedule 13G Amendment)
RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 5.5% beneficial ownership stake in Immatics N.V. as of December 31, 2024.
Summary
- RTW Investments, LP, a Delaware limited partnership, and Roderick Wong, M.D., its Managing Partner and Chief Investment Officer, are the reporting persons.
- The filing is an Amendment No. 1 to Schedule 13G, indicating an update to a previous beneficial ownership report.
- As of December 31, 2024, the reporting persons collectively beneficially own 6,540,540 Ordinary Shares of Immatics N.V.
- This ownership represents 5.5% of Immatics N.V.'s Ordinary Shares outstanding.
- The percentage is calculated based on 119,355,906 Ordinary Shares outstanding, as reported in the Company's Prospectus Supplement filed on October 11, 2024.
- The shares are held by RTW Funds, for which RTW Investments acts as an investment adviser, and Dr. Wong has shared voting and dispositive power.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing disclosing beneficial ownership and does not convey positive or negative sentiment regarding the company's performance or outlook. It is neutral.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Management Comments
- NA
Industry Context
This filing is a standard regulatory disclosure for institutional investors who acquire more than 5% of a company's voting shares. It provides transparency regarding significant ownership stakes, which can be of interest to other investors and market participants. For a biotechnology company like Immatics N.V., institutional ownership by specialized investment firms like RTW Investments, which focuses on healthcare, can signal investor confidence in the company's long-term prospects, particularly its pipeline and technology.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which may influence perceptions of institutional confidence.
- Company Management: Awareness of a significant shareholder's position, though the filing states the shares are not held for the purpose of changing or influencing control.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2024-10-11 | Date of Company's Prospectus Supplement filing, reporting 119,355,906 Ordinary Shares outstanding. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end). |
| 2025-02-14 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Immatics N.V., RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Adviser, Biotechnology, Pharmaceuticals, Healthcare Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.